mitomycin has been researched along with Coagulation, Disseminated Intravascular in 7 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"We examined red cell fragmentation syndrome (RCFS) induced by mitomycin C (MMC) (13 patients), by thrombotic thrombocytopenic purpura (TTP) (17 patients), and by disseminated intravascular coagulation (DIC) (15 patients)." | 7.69 | Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. ( Deguchi, K; Minami, N; Miyanishi, E; Nagaya, S; Oka, K; Tamaki, S; Tanigawa, M; Tsuzi, K; Wada, H; Wakita, Y, 1995) |
"We examined red cell fragmentation syndrome (RCFS) induced by mitomycin C (MMC) (13 patients), by thrombotic thrombocytopenic purpura (TTP) (17 patients), and by disseminated intravascular coagulation (DIC) (15 patients)." | 3.69 | Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. ( Deguchi, K; Minami, N; Miyanishi, E; Nagaya, S; Oka, K; Tamaki, S; Tanigawa, M; Tsuzi, K; Wada, H; Wakita, Y, 1995) |
"We examined various markers in 17 patients with thrombotic thrombocytopenic purpura (TTP), 13 with red cell fragmentation syndrome (RCFS) induced by mitomycin C, and 36 with RCFS caused by disseminated intravascular coagulation (DIC)." | 3.69 | [Plasma level of various markers in patients with thrombotic thrombocytopenic purpura]. ( Shirakawa, S; Tamaki, S; Wada, H, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagaya, S | 2 |
Wada, H | 3 |
Oka, K | 1 |
Tanigawa, M | 1 |
Tamaki, S | 2 |
Tsuzi, K | 1 |
Miyanishi, E | 1 |
Wakita, Y | 2 |
Minami, N | 2 |
Deguchi, K | 1 |
Kobayashi, M | 1 |
Shimura, M | 1 |
Nakase, T | 1 |
Hiyoyama, K | 1 |
Nakano, T | 1 |
Shiku, H | 1 |
Shirakawa, S | 1 |
Yumoto, Y | 2 |
Okuda, T | 2 |
Shimizu, S | 1 |
Kawase, K | 1 |
Li, H | 1 |
Sasano, Y | 1 |
Hori, K | 1 |
Manabu, K | 1 |
Zhang, Q | 1 |
Saito, S | 1 |
Suzuki, M | 1 |
Sadamoto, Y | 1 |
Haruma, K | 1 |
Tokumo, K | 1 |
Teshima, H | 1 |
Murakami, S | 1 |
Sumii, K | 1 |
Kajiyama, G | 1 |
Yamashita, Y | 1 |
Niimoto, M | 1 |
Hattori, T | 1 |
Kato, Y | 1 |
Tashima, M | 1 |
Sawada, H | 1 |
Yamagishi, M | 1 |
Uchino, H | 1 |
7 other studies available for mitomycin and Coagulation, Disseminated Intravascular
Article | Year |
---|---|
Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Cytokines; Disseminated Intravascular | 1995 |
Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Combined Modality Therapy; Disseminat | 1995 |
[Plasma level of various markers in patients with thrombotic thrombocytopenic purpura].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Biomarkers; Blood Coagulation Factors | 1994 |
[FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intrava | 1996 |
Hypercoagulable state and disseminated intravascular coagulation following an effective chemotherapy in tumor-bearing rats.
Topics: Angiotensins; Animals; Antibiotics, Antineoplastic; Disseminated Intravascular Coagulation; Liver Ne | 1998 |
[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 1987 |
[A cancer of unknown primary site with diffuse metastasis to the bone marrow treated effectively with FAM combination chemotherapy].
Topics: Anemia, Myelophthisic; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1988 |